Walter Greenleaf

Walter Greenleaf is a neuroscientist and a medical technology developer working at Stanford University. With over three decades of research and development experience, Walter is considered a leading authority in the field of digital medicine and medical virtual reality technology.

Research Focus: Walter’s current research focus is on developing computer-supported clinical products, with a specific emphasis on applying virtual reality and digital health technology to address difficult problems in behavioral and physical medicine such as Post-traumatic Stress, Anxiety Disorders, Depression, Stroke, Addictions, and Autism Spectrum Disorder. He has served as the Principal Investigator for research projects funded by the NIH and by NASA.

Academic Positions: Walter is currently a Visiting Scholar at Stanford University’s Virtual Human Interaction Lab, and the Director of Technology Strategy at the University of Colorado National Mental Health Innovation Center. He previously served as the Director of the Mind Division, Stanford Center on Longevity, where his focus was on age-related changes in cognition.

Corporate Management: Walter founded and served as CEO for Greenleaf Medical Systems, a medical product development company; InWorld Solutions, a company specializing in the therapeutic use of virtual worlds for behavioral health care; and Virtually Better, a company that develops virtual environments for the treatment of phobias, anxiety disorders, and PTSD. He is currently working with Interaxon as Chief Science Officer.

Current Board Positions: Walter serves on the Board of Directors for Brainstorm: The Stanford Laboratory for Brain Health Innovation and Entrepreneurship; for Cognitive Leap, a company that develops mental health solutions for children; and for Sine Wave. Walter was Senior Vice President of Strategic & Corp. Affairs to MindMaze and founding Chief Science Officer for Pear Therapeutics, a pioneering company in SaMD (Software As Medical Device).